Intra-articular injection of bone marrow aspirate concentrate (BMAC) or adipose-derived stem cells (ADSCs) for knee osteoarthritis: a prospective comparative clinical trial
- PMID: 37170296
- PMCID: PMC10176826
- DOI: 10.1186/s13018-023-03841-2
Intra-articular injection of bone marrow aspirate concentrate (BMAC) or adipose-derived stem cells (ADSCs) for knee osteoarthritis: a prospective comparative clinical trial
Abstract
Background: We determined whether autologous mesenchymal stem cells (MSCs) injections provide clinical and functional improvements in knee osteoarthritis (KOA) patients, and whether the results differ between autologous bone marrow cells (BMAC) and adipose-derived stromal cells (ADSCs).
Methods: Between January 2021 and April 2022, 51 patients undergoing intra-articular injection of BMAC and 51 patients undergoing intra-articular injection of ADSCs were prospectively recruited. The Kellgren and Lawrence (K-L) classification was used to grade the severity of osteoarthritis. Knee Injury and Osteoarthritis Outcome Score (KOOS), Oxford Knee Score (OKS), and visual analog scale (VAS) were collected for all 102 patients in the previous week before the procedures, and at the one and 6 months from injection.
Results: Knee KOOS scores, knee OKS scores, and VAS pain scores changed in similar ways in the two treatment groups. Both treatment groups demonstrated significant improvement pre-procedure to post-procedure in knee KOOS scores (p < 0.0001), knee OKS scores (p < 0.0001), and VAS pain scores (p < 0.0001). Patients with K-L grade 2 showed better functional and clinical outcomes than patients with K-L grades 3 and 4 (p < 0.0001).
Conclusion: Both intra-articular BMAC and ADSC injections significantly improved pain and functional outcomes at 6-month follow-up in patients with KOA. The difference between BMAC and ADCSs groups as tissue sources of MSCs was not statistically significant in terms of clinical and functional outcomes.
Keywords: Adipose; Bone marrow; Knee; Mesenchymal stem cells; Osteoarthritis.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Functional Outcomes Following Microfragmented Adipose Tissue Versus Bone Marrow Aspirate Concentrate Injections for Symptomatic Knee Osteoarthritis.Stem Cells Transl Med. 2019 Nov;8(11):1149-1156. doi: 10.1002/sctm.18-0285. Epub 2019 Jul 21. Stem Cells Transl Med. 2019. PMID: 31328447 Free PMC article.
-
Bone marrow aspirate concentrate versus platelet-rich plasma for treating knee osteoarthritis: a one-year non-randomized retrospective comparative study.BMC Musculoskelet Disord. 2022 Jan 3;23(1):23. doi: 10.1186/s12891-021-04910-5. BMC Musculoskelet Disord. 2022. PMID: 34980045 Free PMC article.
-
Bone marrow aspirate concentrate injections provide similar results versus viscosupplementation up to 24 months of follow-up in patients with symptomatic knee osteoarthritis. A randomized controlled trial.Knee Surg Sports Traumatol Arthrosc. 2022 Dec;30(12):3958-3967. doi: 10.1007/s00167-021-06793-4. Epub 2021 Nov 12. Knee Surg Sports Traumatol Arthrosc. 2022. PMID: 34767030 Clinical Trial.
-
Role of Scaffolds, Subchondral, Intra-Articular Injections of Fresh Autologous Bone Marrow Concentrate Regenerative Cells in Treating Human Knee Cartilage Lesions: Different Approaches and Different Results.Int J Mol Sci. 2021 Apr 8;22(8):3844. doi: 10.3390/ijms22083844. Int J Mol Sci. 2021. PMID: 33917689 Free PMC article. Review.
-
Safety and Efficacy of Injecting Mesenchymal Stem Cells Into a Human Knee Joint To Treat Osteoarthritis: A Systematic Review.Cureus. 2022 May 8;14(5):e24823. doi: 10.7759/cureus.24823. eCollection 2022 May. Cureus. 2022. PMID: 35693367 Free PMC article. Review.
Cited by
-
Transplantation of three mesenchymal stem cells for knee osteoarthritis, which cell and type are more beneficial? a systematic review and network meta-analysis.J Orthop Surg Res. 2024 Jun 20;19(1):366. doi: 10.1186/s13018-024-04846-1. J Orthop Surg Res. 2024. PMID: 38902778 Free PMC article. Review.
-
Clinical outcomes of autologous adipose-derived mesenchymal stem cell combined with high tibial osteotomy for knee osteoarthritis are correlated with stem cell stemness and senescence.J Transl Med. 2024 Nov 18;22(1):1039. doi: 10.1186/s12967-024-05814-3. J Transl Med. 2024. PMID: 39558365 Free PMC article. Clinical Trial.
-
Bone Marrow Aspirate Concentrate for Treatment of Primary Knee Osteoarthritis: A Prospective, Single-Center, Non-randomized Study with 2-Year Follow-Up.Indian J Orthop. 2024 May 9;58(7):894-904. doi: 10.1007/s43465-024-01168-6. eCollection 2024 Jul. Indian J Orthop. 2024. PMID: 38948370
-
Navigating the Therapeutic Landscape: A Comprehensive Review of Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate in Knee Osteoarthritis.Cureus. 2024 Feb 23;16(2):e54747. doi: 10.7759/cureus.54747. eCollection 2024 Feb. Cureus. 2024. PMID: 38524005 Free PMC article. Review.
-
Arthroscopy With Adipose-Derived Stromal Vascular Fraction Using a Selective Tissue Engineering Photo-Stimulation Technique for the Treatment of Mild to Moderate Knee Osteoarthritis.Arthrosc Tech. 2024 May 4;13(8):103015. doi: 10.1016/j.eats.2024.103015. eCollection 2024 Aug. Arthrosc Tech. 2024. PMID: 39233810 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous